StockTrendNews.com

		US Markets in: hrs min sec

Set StockTrendNews.com as your Homepage! - Click Here

Home About Us Subscribe Contact

StockTrendNews (STN) Exclusive: Idera Pharmaceuticals, Inc

Enter Symbol or Keywords

Revenue for Idera Pharmaceuticals Increased by 36.71% over its most recent 12 months reports T12-NEWS

Stock Quote: (NGM:IDRA)

11/17/2009

3.69

-0.07

-1.86%

19,950

Revenue for Idera Pharmaceuticals Increased by 36.71% over its most recent 12 months reports T12-NEWS

Last

Price Change

% Chg

Volume

New York, New York, November 17, 2009,T12-NEWS reports that Revenue for Idera Pharmaceuticals (NASDAQ:IDRA) for its trailing twelve months (TTM) ended September 30, 2009 increased by 36.71% to $30,579 ... read full story

Website Address:	www.hybridon.com
Industry:	Vaccine, Antibodies, Immunities

Most Recent STN Exclusives

07/30/2010

EBITDA for AirTran Reaches Twelve Year High

07/30/2010

EBITDA for Union Pacific Reaches Sixteen Year High

07/30/2010

Fourteen Year High in EBITDA for Mettler-Toledo

07/30/2010

CA's EBITDA Hits Nine Year High

07/30/2010

EBITDA for Intuitive Surgical Reaches Nine Year High

07/30/2010

StockDiagnostics.com Reiterates Omnicom Group's OPS Ranking of "2"

07/30/2010

Four Year Low in Free Cash Flow for Embotelladora Andina

07/30/2010

Two Year High in Free Cash Flow for Janus Capital

07/30/2010

Free Cash Flow Decreases 91% for Coca-Cola FEMSA

07/30/2010

StockDiagnostics.com Reiterates Safeway's OPS Ranking of "2"

Interactive Chart: IDRA

Flash Player 9 or higher is required to view the chart
Click here to download Flash Player now

More STN Exclusives for: IDRA

05/18/2010

EBITDA for Idera Pharmaceuticals Deteriorates 773%

05/17/2010

Most recent 12 month Revenue for Idera Pharmaceuticals Increased by 21.09% as reported by T12-NEWS

05/14/2010

Free Cash Flow Improves 52% for Idera Pharmaceuticals

... more IDRA exclusives

Other News Sources: IDRA

07/08/2010

Idera Pharmaceuticals Announces Issuance of New Patents for Its Toll-like Receptor-Targeted Compounds

06/21/2010

Idera Pharmaceuticals Announces the Election of Eve E. Slater, M.D., F.A.C.C., to Its Board of Directors

06/08/2010

Idera Pharmaceuticals Announces Preliminary Data from Phase 1 Clinical Trial of IMO-3100, a Toll-like Receptor Antagonist Drug Candidate for Autoimmune and Inflammatory Diseases

... more IDRA news from other sources

Daily Market Updates

07/30/2010

Stocks End July with Strongest Monthly Gains in a Year

Stocks ended flat and closed July with the strongest monthly gains in a year. The markets were volatile throughout the session following mixed economic data earlier. Recovery concerns were renewed after GDP growth slowed in Q2, but Chicago PMI jumped ... read full story